by Impulse Dynamics | Aug 23, 2019 | Press Releases
NEWS First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device. Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in...
by Impulse Dynamics | Mar 21, 2019 | Press Releases
NEWS Impulse Dynamics receives FDA approval for breakthrough Optimizer® Smart System delivering CCM™ therapy for treatment of heart failure Orangeburg, New York, March 21, 2019 – Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering...
by Impulse Dynamics | May 28, 2018 | Press Releases
NEWS Clinical Registry Data and recently published FIX-HF-5C were presented at the Late-Breaking Clinical Trial Session at EHF 2018 Stuttgart, Germany, May 28th, 2018 – Impulse Dynamics Germany, GmbH announced results on “Real World” experience from its European...
by Impulse Dynamics | May 10, 2018 | Press Releases
NEWS FIX-HF-5C Late-Breaking Clinical Trial Data Presented at HRS 2018 with Simultaneous Publication in the JACC: Heart Failure Orangeburg, New York, May 10, 2018 – Impulse Dynamics (USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of...
by Impulse Dynamics | Dec 18, 2017 | Press Releases
NEWS The CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in China Orangeburg, New York & Stuttgart, Germany. December 18, 2017 – The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system...
Recent Comments